EUVIMEDEUVIMED entdecken
Crossref

Synthesis, characterization, and anti‐inflammatory properties of novel ethyl 3‐benzoyl‐7‐(trifluoromethyl)indolizine‐1‐carboxylate derivatives: In silico and in vitro analysis

Harshada Rambaboo Singh, Prajjwal Kushwaha, Reetika Tandon, Nidhi Srivastava, Sandeep Chandrashekharappa iD

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14514 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Harshada Rambaboo Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Raebareli, Transit Campus, Lucknow, India. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Indolizines. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Series of 7‐(Trifluoromethyl) substituted indolizine 4a‐g was synthesized using the one‐pot method. Spectroscopic techniques such as IR, 1 H‐NMR, 13 C‐NMR, and HRMS were used for the structure confirmation of newly synthesized compounds. These 4a‐g compounds were tested for their anti‐inflammatory activity. In this study, we identified novel indolizine derivative compounds 4a‐g selectively targeting COX‐2 enzyme, tumor necrosis factor‐α (TNF‐α) and, interleukin‐6 (IL‐6). The in silico docking studies of 4a‐g showed that these compounds have a higher affinity for COX‐2 enzyme, TNF‐ α, and IL‐6. In silico ADME profile analysis predicts that these compounds have good gastrointestinal tract and blood–brain barrier absorption. In vitro studies showed that compound 4d significantly reduces the level of COX‐2 enzymes as compared to indomethacin. Compounds 4e , 4f , and 4a were also found to significantly reduce the level of TNF‐α, while compounds 4f , 4g , and 4d , showed a reduction in the level of IL‐6 when compared to indomethacin. Compounds 4a , 4d , and 4f also reduces nitric oxide (NO) level, compared to indomethacin. Overall, the current study illustrates significant anti‐inflammatory activities of these novel 7‐(Trifluoromethyl) substituted indolizine derivatives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalIndolizinesCyclooxygenase 2Molecular StructureStructure-Activity RelationshipTumor Necrosis Factor-alphaInterleukin-6Anti-Inflammatory AgentsIndomethacinMolecular Docking Simulation

Stichwörter der Autor:innen

COX‐2IL‐6TNF‐αanti‐inflammatory activitycharacterizationindolizineinflammation

Substanzen

Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2Tumor Necrosis Factor-alphaInterleukin-6Anti-Inflammatory AgentsIndomethacinIndolizines

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Raebareli, Transit Campus, Lucknow, India.
  • Department of Biotechnology, National Institute of Pharmaceutical Education and Research Raebareli, Transit Campus, Lucknow, India.

ORCID-Profile: Sandeep Chandrashekharappa

Zitieren

APA

Singh, H. R., Kushwaha, P., Tandon, R., Srivastava, N., & Chandrashekharappa, S. (2024). Synthesis, characterization, and anti‐inflammatory properties of novel ethyl 3‐benzoyl‐7‐(trifluoromethyl)indolizine‐1‐carboxylate derivatives: In silico and in vitro analysis. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14514

Vancouver

Singh HR, Kushwaha P, Tandon R, Srivastava N, Chandrashekharappa S. Synthesis, characterization, and anti‐inflammatory properties of novel ethyl 3‐benzoyl‐7‐(trifluoromethyl)indolizine‐1‐carboxylate derivatives: In silico and in vitro analysis. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14514

BibTeX
@article{Singh2024,
  author = {Singh, Harshada Rambaboo and Kushwaha, Prajjwal and Tandon, Reetika and Srivastava, Nidhi and Chandrashekharappa, Sandeep},
  title = {Synthesis, characterization, and anti‐inflammatory properties of novel ethyl 3‐benzoyl‐7‐(trifluoromethyl)indolizine‐1‐carboxylate derivatives: In silico and in vitro analysis},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14514}
}
Kostenlos starten →